85 related articles for article (PubMed ID: 312839)
1. Immune responses to weakly immunogenic virally induced tumors. III. Genetically unrestricted cytolysis of allogeneic tumor target cells.
Devens B; Naor D
J Immunol; 1979 Apr; 122(4):1397-401. PubMed ID: 312839
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to weakly immunogenic virally induced tumors. I. Overcoming low responsiveness by priming mice with a syngeneic in vitro tumor line or allogeneic cross-reactive tumor.
Galili N; Devens B; Naor D; Becker S; Klein E
Eur J Immunol; 1978 Jan; 8(1):17-22. PubMed ID: 639838
[TBL] [Abstract][Full Text] [Related]
3. Immune responses to weakly immunogenic virally induced tumors. II. Suppressive effects of the in vivo carried tumor YAC.
Devens B; Galili N; Deutsch O; Naor D; Klein E
Eur J Immunol; 1978 Aug; 8(8):573-8. PubMed ID: 699954
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VII. Kinetic studies on various parameters of effects induced with suppressor cells.
Deutsch O; Devens B; Naor D
Isr J Med Sci; 1980 Jul; 16(7):530-7. PubMed ID: 6447122
[TBL] [Abstract][Full Text] [Related]
5. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VIII. Characterization of suppressor cells.
Deutsch O; Devens B; Naor D
Isr J Med Sci; 1980 Jul; 16(7):538-44. PubMed ID: 6447123
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
Schenk PJ; Howe ML
J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
[TBL] [Abstract][Full Text] [Related]
7. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
Plata F; Cerottini JC; Brunner KT
Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
[TBL] [Abstract][Full Text] [Related]
8. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
9. Immune response to weakly immunogenic virally induced tumors. IX. Mice injected with the in vitro variant of YAC tumor (YAC-1) resist lethal doses of the tumorigenic YAC cells.
Devens B; Deutsch O; Avraham Y; Naor D
Immunobiology; 1981; 159(4-5):432-43. PubMed ID: 7287048
[TBL] [Abstract][Full Text] [Related]
10. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
11. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice.
Lamon EW; Gatti RA; Kiessling R; Fenyö EM
Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367
[TBL] [Abstract][Full Text] [Related]
13. Detection of a unique antigen on radiation leukemia virus-induced leukemia B6RV2.
Nakayama E; Uenaka A; Stockert E; Obata Y
Cancer Res; 1984 Nov; 44(11):5138-44. PubMed ID: 6091870
[TBL] [Abstract][Full Text] [Related]
14. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
Jiang D; Flyer DC
J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
16. Expression of H-2b alloantigens in a variant of a Moloney virus-induced YAC (H-2a) lymphoma.
Kedar E; Schwartzbach M; Klein E
Eur J Cancer Clin Oncol; 1982 Sep; 18(9):861-5. PubMed ID: 6185344
[TBL] [Abstract][Full Text] [Related]
17. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
[TBL] [Abstract][Full Text] [Related]
18. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
19. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
[TBL] [Abstract][Full Text] [Related]
20. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.
Iezzi G; Rivolta L; Ronchetti A; Martin-Fontecha A; Rosato A; Protti MP; Sabbadini MG; Bellone M
Cancer Res; 1997 Jul; 57(13):2564-8. PubMed ID: 9205054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
